Summary.-The lognormal parametric statistical model can provide, for groups of carcinoma cervix patients, good estimates of long-term survival fractions several years earlier than would otherwise be possible. The present paper extends this model work to head and neck cancer by using a minimum chi-squared test for goodness of fit (P > 0.05), to study the distribution of survival times of patients who died with their cancer present. Some 12,000 case histories were available from 7 hospital registries, 4 regional cancer registries and one national registry (the OPCS). All histories were followed up for at least 10 years subsequent to treatment and could be grouped into one of 8 cancer sites: antrum, floor of mouth, larynx, nasopharynx, pyriform fossa, post cricoid, tonsil and tongue. The theoretical distributions investigated were the lognormal, negative exponential and skew exponential. The results showed that the lognormal provided the best overall fit to the data, although the range of optimum values for the lognormal parameter, S, differed with cancer site. The optimum range did, however, usually include the value S = 0 45. These results will now permit the second stage of validation of the lognormal model to proceed for head and neck cancers.
THE USE of parametric statistical models to predict the long term survival rates for groups of patients treated for cancer was suggested many years ago, Boag, 1948; Berkson and Gage, 1952; Haybittle, 1959 Haybittle, , 1965 . Until recently, however, the models could not be adequately tested due to the lack of patient data with sufficiently detailed follow-up, and the lack of the computer facilities necessary for the lengthy iterative procedures. It has been shown that a lognormal model of the type in Fig. 1 is the most consistent model for groups of staged carcinoma cervix patients, when a value is assumed for the lognormal parameter S in the range S = 0-35-S 0 40 (Mould and Boag, 1975) .
The validation of this lognormal model for carcinoma cervix, was made in 2 tests. Firstly, the actual survival time distribution of each group of patients was compared with the postulated analytical form, choosing the model parameters to give the best fit. The goodness of fit was assessed using a minimum chi-squared test. The optimum analytical form is significant only in that it provides a good empirical fit to the data. No biological explanation is suggested for the pattern of lognormality. Secondly, accepting only the limited survival data which would have been available a few years (2, 3 or 4 years) after the end of a 5-year treatment period under review, the model was used to predict the 10-year or 15-year survival rates. The predicted values were then compared with observed 1 O-year and 15-year results, taking standard errors into account.
The present paper extends this earlier work (Mould and Boag, 1975) Boag (1948 Boag ( , 1949 Boag ( , 1951 , Berg (1965) and Wood and Boag (1950) , and for cancer at other sites by Tivey (1954) , Sorensen (1958) , Smithers et al. (1952) , Haybittle (1959) , Ronnike (1968) and Rabbe (see Mould, 1975 SURVIVAL TIME ( t ) and Q =J(N (t). dt although a x2 test using a single set of estimated lognormal parameters has occasionally been used, a thorough minimum x2 test such as that which will be described in this paper has never previously been attempted. The head and neck data used by Berg (1965) (OPCS, 1975) . That part of the OPCS data relevant to head and neck cancer was made available to the authors in the form of individual survival times of patients with proven histology who eventually died with their cancer present. Data were also obtained from various Regional Cancer Registries but only for a minimum follow-up period of 10 years.
Individual hospital cancer registries vary wvidely in their methods of data collection, storage and retrieval. In the best registries, most treated cases will have been histologically verified and have well-recorded long follow-ups, but there will often be the disadvantage that the numbers of cases for any given treatment site are too small for this type of study. This was overcome by choosing 2 radiotherapy centres with a large intake of patients, both of which have excellent records dating back to the early 1930s. The Christie Hospital, Manchester and the Royal Marsden Hospital, London are probably the only 2 hospital registries in the U.K. with such a wealth of reliable information for head and neck cancer. The 3 London teaching hospitals chosen, Westminster, University College and Middlesex, did not always have sufficient numbers of cases for analysis, and when this occurred, the 3 sets of data were combined. Addenbrooke's Hospital, Cambridge was chosen since work on statistical models had already been carried out at this centre (Haybittle, 1959) .
The head and neck anatomical region was chosen for this study since it contains the sites of some cancers with a good prognosis, which require a long term rather than short term survival rate as a criterion for success of treatment. Also, an earlier study had been conducted by Wood and Boag (1950) using Hammersmith Hospital data for the treatment period 1934-45 for several individual head and neck treatment sites, but the number of cases for each site was usually less than 50. In the more recent follow-up of this data, the numbers of cancer deaths increased only slightly.
Eight treatment sites within the head and neck have been chosen for the study (Table I ). It was not usually possible to divide the data into staged groups. The Wood and Boag data (1950) contained all the sites in Table I with the exception of pyriform fossa which had been grouped with other sites under the general heading of pharynx. - Table II gives a breakdown by registry and treatment site of some 12,000 cases used in this study. Only the Christie Hospital and OPCS data have a minimum follow-up period of 15 years.
Mathematical formulae.-Several analytical forms have been proposed as a representation for the death rate (N(t), Fig. 1 ) of cases who die with cancer present. They have included the lognormal curve (equation 1), the negative exponential (equation 2) and the skew exponential (equation 3).
N(t) = No I t .exp (-y t)
The actual survival time distribution of a group of patients has been compared with the postulated analytical form, choosing the parameters (M and S for the lognormal; a for the negative exponential; y and 4 for the skew exponential) to give the best fit, and using a computer to assess the goodness of fit by a minimum x2 test.
Minimum X2 test-Agreement between the observed survival time distribution and the proposed formulae was tested by grouping survival times into 4-monthly periods between 0-1 year,* 6-monthly periods between 1-2 years, annual periods between 2-5 years and longer periods thereafter, until a survival time of 10 or 15 years subsequent to treatment was reached. Observed and theoretical numbers in each interval were compared, using a x2 test for the data in Table II and for 7 lognormal curves with fixed values of S equal * For small sample series these groups were sometimes combined, and the initial 2 periods changed to 0-6 months and 6-12 months. (4), w%Nhere r is integral and 1 < r < 7. This 4 = 2/(1 + r) (4) restriction ensured that integration of equation (3) would lead to a complete gamma function which could be easily evaluated.
The theoretical parameters (M, ox, y) were varied stepwise until a minimum x2 wcas found, and the computer then printed out this value together w%Nith the corresponding values of the parameters.
RESULTS
The data of Wood and Boag (1950) with additional follow-up were tested using the lognormal cutrves and the results are given in Table III . The number of cancer deaths in each group is too small for any firm conclusions to be drawn, but it does suggest that the lognormal may provide a good fit for most sites, when a value is assumed for the parameter S in the range S 0 35-S-045.
Each site in Table I will be considered individually, since it was found that the The results refer to 63 different groups of patients with between 6 and 11 groups per site (Tables III-XII) . The number of cancer deaths/group was in the range 77-700, and one-third of the groups contained more than 180 patients each. In general, for the smaller groups, lognormal distributions with several values of S were found to give adequate fits, whereas for the larger groups fewer fitted the data. Nevertheless, for 6 of the 8 groups containing more than 300 patients at least one value of S was found which gave an adequate fit (P > 0.05) to a lognormal distribution. Fig. 2 Tables  IV-xI 
Antrum
The lognormal curve with S in the range 0 45-0 50 provided the best fit to the data (Table IV) . None of the 6 groups could be fitted by a negative exponential, and 3 groups, B, D and " JKL ", could not be fitted by any of the skew exponentials. C = 0 5 was the best skew exponential, fitting 3 groups.
Floor of mouth
The lognormal curve with S in the range 0 45-0 50 provided the best fit to the data (Table V) . Only 2 of the 7 groups, F and "JKL ", could be fitted by the negative exponential, and 3 groups, A, B and D, could not be fitted by any of the skew exponentials.
-0-5 was the best skew exponential fitting 4 groups.
Larynx
The lognormal curve with S in the range 0 45-0-55 provided the best fit to the data (Table VI) . Only 4 of the 11 groups could be fitted by a negative exponential, G, H, J and K, and 4 groups, A, B, D and F, could not be fitted by any of the skew exponentials. C 0 4 was the best skew exponential, fitting 7 groups. The curve with C 0 5 fitted 6 groups.
Nasopharynx
The lognormal curve with S in the range 0'45-0 55 fitted all 7 groups (Table  VII) . Five groups were fitted by the negative exponential, and 6 groups by skew exponentials in the range C-0-29-0 40. The curve with ( 0'5 fitted 5 groups.
Post cricoid
The lognormal curve with S-045 provided the best fit to the data, with S 0 40 only slightly worse (Table VIII) . Group H which could be fitted by most lognormals was only fitted by a single skew exponential, that with C 1. The combined group "JKL " was the only other group fitted by the skew exponential -1, and = 0 5 was the optimum skew exponential, fitting 5 of the 8 groups. The negative exponential fitted only 3 of the groups, C, F and " JKL ".
Pyriform fossa
The lognormal curve with S = 0 40 fitted all but one of the 7 groups of data, lognormal with S 0 45 failed to fit 3 groups (Table IX) . Group C which could not be fitted by any lognormal, was not fitted by negative exponential or skew exponentials. The negative exponential fitted only 3 groups of data, A, D and " JKL ", and the optimum skew exponential was = 0 5 which fitted 5 of the 7 groups.
Tongue
The lognormal curve with S -0 45 provided the best fit to the data, 8 groups out of 10, and S -0 40 fitted 6 groups ( Table X) . The 2 groups, B and G, 188 12,000 CASES OF HEAD AND NECK CANCER 189 which could not be fitted by any lognormal were also not fitted by a negative exponential or skew exponential. The negative exponential fitted only 2 groups, H and K. The optimum skew exponential was C 0 5, but this fitted only 5 of the 10 groups. Data were also available from the Trent Regional Registry, but only for a minimum follow-up period of 5 years, as opposed to the 10 years for the data in Table II Wood and Boag (44 patients) . Of the remaining 2 groups, C with 177 cases was fitted by the lognormal with S in the range S-0 40-S = 0.45, but neither the lognormals, negative exponential nor skew exponentials fitted Group B data of 506 cases. It will be noted from Table X that the combined Group B of tongue cancers could not be fitted by any lognormal curve.
Tonsil
The lognormal curve with S = 0 45 provided the best fit to the data, 6 out of 7 groups (Table XI) . For this site, the skew exponential with C = 0 33 also fitted 6 of the 7 groups. Skew exponentials with C = 0-29 and C = 0 40 fitted 5 groups. The negative exponential fitted only 3 groups, A, B and " JKL".
CONCLUSIONS
The lognormal model with a value assumed for the parameter S in the range S 0= 035-S O040 has already been seen to provide a useful alternative to the actuarial method of calculating survival rates for series of carcinoma cervix patients, even when follow-up data are sufficiently extensive to allow the latter method to be used (Mould and Boag, 1975; Mould, 1976) .
In the present study for head and neck cancer it has been shown that the distribution of survival times of those patients who die with their cancer present can be reasonably represented by a lognormal curve in a large proportion of the patient groups. However, the range of optimum values for the parameter S differs with treatment site (Table XII) . The negative exponential and skew exponential curves do not provide a suitable alternative to the lognormal curve.
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